Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.12M Sell
67,492
-3,016
-4% -$348K 1.04% 21
2025
Q4
$7.42M Sell
70,508
-20,958
-23% -$1.97M 0.96% 26
2025
Q3
$7.68M Sell
91,466
-13,809
-13% -$1.14M 1.02% 22
2025
Q2
$8.33M Buy
105,275
+21,937
+26% +$1.74M 1.24% 17
2025
Q1
$7.48M Buy
83,338
+9,870
+13% +$922K 1.24% 21
2024
Q4
$7.31M Buy
73,468
+18,775
+34% +$1.94M 1.32% 14
2024
Q3
$6.21M Buy
54,693
+7,116
+15% +$845K 1.22% 20
2024
Q2
$5.89M Sell
47,577
-202
-0.4% -$26K 1.64% 15
2024
Q1
$6.3M Buy
47,779
+4,604
+11% +$567K 1.76% 11
2023
Q4
$4.71M Buy
43,175
+2,847
+7% +$296K 1.62% 13
2023
Q3
$4.15M Buy
40,328
+2,200
+6% +$237K 1.62% 15
2023
Q2
$4.4M Buy
38,128
+4,180
+12% +$475K 1.87% 15
2023
Q1
$3.61M Sell
33,948
-5,316
-14% -$574K 1.71% 12
2022
Q4
$4.36M Buy
39,264
+451
+1% +$46.1K 2.45% 7
2022
Q3
$3.93M Buy
38,813
+1,521
+4% +$136K 2.23% 9
2022
Q2
$3.4M Buy
37,292
+608
+2% +$53.9K 2.16% 8
2022
Q1
$3.01M Buy
36,684
+18,500
+102% +$1.46M 1.99% 9
2021
Q4
$1.39M Buy
+18,184
New +$1.45M 1.11% 27

Other funds holding MRK

Lifeworks Advisors's MRK Position: Q1 2026 in Review

Lifeworks Advisors reduced its Merck (MRK) stake by 4.3% in Q1 2026, selling an estimated $348K and leaving 67,492 shares worth $8.12M. The position accounts for 1.04% of the portfolio, ranked #21.

Lifeworks Advisors first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.33M in Q2 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Lifeworks Advisors held 67,492 shares of Merck worth $8.12M as of Q1 2026.
  • Lifeworks Advisors sold 3,016 Merck shares in Q1 2026, an estimated $348K.
  • Merck made up 1.04% of Lifeworks Advisors's portfolio in Q1 2026, its #21 holding.
  • Lifeworks Advisors first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • Lifeworks Advisors's Merck position peaked at $8.33M in Q2 2025.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Lifeworks Advisors's 13F filing for Q1 2026, filed 4 May 2026.